Flow cytometric characterisation of acute leukaemia in adolescent and adult Ethiopians

被引:0
作者
Alemu, Jemal [1 ,2 ,3 ]
Gumi, Balako [3 ]
Tsegaye, Aster [1 ]
Sherif, Abdulaziz [4 ]
Tadesse, Fisihatsion [4 ]
Gebremedhin, Amha [4 ]
Howe, Rawleigh [2 ]
机构
[1] Addis Ababa Univ, Coll Hlth Sci, Dept Med Lab Sci, Addis Ababa, Ethiopia
[2] Armauer Hansen Res Inst, Addis Ababa, Ethiopia
[3] Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia
[4] Addis Ababa Univ, Coll Hlth Sci, Dept Internal Med, Addis Ababa, Ethiopia
关键词
flow cytometry; acute leukaemia; Ethiopia; phenotype; cell surface biomarker; cytoplasmic biomarker; ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; B-CELL; EXPRESSION; CLASSIFICATION; IMMUNOPHENOTYPE; MUTATIONS; DIAGNOSIS; SUBGROUP; IMPACT;
D O I
10.4102/ajlm.v14i1.2394
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Flow cytometric characterisation of acute leukaemia is a key diagnostic approach for clinical management of patients, but is minimally practised in resource-constrained settings like Ethiopia. Objective: This study aimed to determine the immunophenotypes of acute leukaemia by flow cytometry at Tikur Anbessa Specialised Hospital, Addis Ababa, Ethiopia. Methods: A cross-sectional study was conducted on adolescent and adult inpatients consecutively admitted from April 2019 to June 2021. Peripheral blood samples were stained for surface and cytoplasmic markers, and analysed by four-colour flow cytometry. Results: Of 140 cases aged 13 years to 76 years, 74 (53%) were men and 66 (47%) were women, 68 (49%) had acute lymphocytic leukaemia (ALL), 65 (46 %) had acute myelogenous leukaemia (AML), and 7 (5.0%) had acute leukaemia non-otherwise specified. Acute lymphocytic leukaemia was more common among adolescent and male cases; AML was more common among adult and female cases. Among ALL subtypes, B-cell acute lymphocytic leukaemia cases (73.5%) were more common than T-cell acute lymphocytic leukaemia (26.5%). A subset of acute leukaemia, CD19+/CD56+ AML was identified in 3 cases (6% of AML). Of the B-cell ALL cases, 21 (42%) were CD34+/CD10+/CD66c+, 10% were CD34+/CD10+/CD66c-, 32% were CD34-/CD10+, and 6% were CD34+/CD10-. An unexpectedly high number of T-cell ALL cases that lacked surface CD3 were observed to have significantly higher levels of aberrantly expressed myeloid markers. Conclusion: We observed multiple phenotypes identifying subtypes of acute leukaemia cases, extending our previous studies in Ethiopia. What this study adds: This study extends previous studies by describing phenotypically defined subsets of ALL and AML which, in addition to diagnosis, may have useful prognostic value for clinicians.
引用
收藏
页数:10
相关论文
共 47 条
  • [31] Favorable impact of the t(9;11) in childhood acute myeloid leukemia
    Rubnitz, JE
    Raimondi, SC
    Tong, X
    Srivastava, DK
    Razzouk, B
    Shurtleff, SA
    Downing, JR
    Pui, CH
    Ribeiro, RC
    Behm, FG
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (09) : 2302 - 2309
  • [32] Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Adults
    Saleh, Khalil
    Fernandez, Alexis
    Pasquier, Florence
    [J]. CANCERS, 2022, 14 (07)
  • [33] Flow cytometry in acute leukemia
    Saxena R.
    Anand H.
    [J]. Indian Journal of Hematology and Blood Transfusion, 2008, 24 (4) : 146 - 150
  • [34] Frequency of CD34 and CD10 Expression in Adolescent and Young Adult Patients Having Precursor B-cell Acute Lymphoblastic Leukemia and Its Correlation With Clinical Outcomes: A Single-Center Study
    Shah, Munawar Ali
    Ahmad, Usman
    Mahmood, Muhammad Tariq
    Ahmad, Asad H.
    Abu Bakar, Muhammad
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (01)
  • [35] Flow Cytometry in the Diagnostic Laboratory Workup of Acute Lymphoblastic Leukemias
    Sharma, Praveen
    Srinivasan, Tharageswari
    Mallik, Nabhajit
    [J]. INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2023, 44 (05) : 474 - 481
  • [36] Acute myelogenous leukemia
    Shipley, Joshua L.
    Butera, James N.
    [J]. EXPERIMENTAL HEMATOLOGY, 2009, 37 (06) : 649 - 658
  • [37] Shurtleff SA, 1995, LEUKEMIA, V9, P1985
  • [38] High-risk acute promyelocytic leukemia with unusual T/myeloid immunophenotype successfully treated with ATRA and arsenic trioxide-based regimen
    Singh, Zeba N.
    Duong, Vu H.
    Koka, Rima
    Zou, Ying
    Sawhney, Sameer
    Tang, Li
    Baer, Maria R.
    Ambulos, Nicholas
    El Chaer, Firas
    Emadi, Ashkan
    [J]. JOURNAL OF HEMATOPATHOLOGY, 2018, 11 (03) : 67 - 74
  • [39] Classification systems for acute and chronic leukaemias
    Szczepanski, T
    van der Velden, VHJ
    van Dongen, JJM
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2003, 16 (04) : 561 - 582
  • [40] Etiology of Acute Leukemia: A Review
    Tebbi, Cameron K.
    [J]. CANCERS, 2021, 13 (09)